These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 17948053)

  • 1. Structural basis for the recruitment of ERCC1-XPF to nucleotide excision repair complexes by XPA.
    Tsodikov OV; Ivanov D; Orelli B; Staresincic L; Shoshani I; Oberman R; Schärer OD; Wagner G; Ellenberger T
    EMBO J; 2007 Nov; 26(22):4768-76. PubMed ID: 17948053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small Molecule Antagonists of the DNA Repair ERCC1/XPA Protein-Protein Interaction.
    Obermann R; Yemane B; Jarvis C; Franco FM; Kyriukha Y; Nolan W; Gohara B; Krezel AM; Wildman SA; Janetka JW
    ChemMedChem; 2024 Apr; 19(8):e202300648. PubMed ID: 38300970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational determinants for the recruitment of ERCC1 by XPA in the nucleotide excision repair (NER) Pathway: structure and dynamics of the XPA binding motif.
    Fadda E
    Biophys J; 2013 Jun; 104(11):2503-11. PubMed ID: 23746523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The XPA-binding domain of ERCC1 is required for nucleotide excision repair but not other DNA repair pathways.
    Orelli B; McClendon TB; Tsodikov OV; Ellenberger T; Niedernhofer LJ; Schärer OD
    J Biol Chem; 2010 Feb; 285(6):3705-3712. PubMed ID: 19940136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy.
    Gentile F; Tuszynski JA; Barakat KH
    J Mol Graph Model; 2016 Apr; 65():71-82. PubMed ID: 26939044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and physical interactions between ERCC1 and MSH2 complexes for resistance to cis-diamminedichloroplatinum(II) in mammalian cells.
    Lan L; Hayashi T; Rabeya RM; Nakajima S; Kanno Si; Takao M; Matsunaga T; Yoshino M; Ichikawa M; Riele Ht; Tsuchiya S; Tanaka K; Yasui A
    DNA Repair (Amst); 2004 Feb; 3(2):135-43. PubMed ID: 14706347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A disease-associated XPA allele interferes with TFIIH binding and primarily affects transcription-coupled nucleotide excision repair.
    van den Heuvel D; Kim M; Wondergem AP; van der Meer PJ; Witkamp M; Lambregtse F; Kim HS; Kan F; Apelt K; Kragten A; González-Prieto R; Vertegaal ACO; Yeo JE; Kim BG; van Doorn R; Schärer OD; Luijsterburg MS
    Proc Natl Acad Sci U S A; 2023 Mar; 120(11):e2208860120. PubMed ID: 36893274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A truncated human xeroderma pigmentosum complementation group A protein expressed from an adenovirus sensitizes human tumor cells to ultraviolet light and cisplatin.
    Rosenberg E; Taher MM; Kuemmerle NB; Farnsworth J; Valerie K
    Cancer Res; 2001 Jan; 61(2):764-70. PubMed ID: 11212280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA repair gets physical: mapping an XPA-binding site on ERCC1.
    Croteau DL; Peng Y; Van Houten B
    DNA Repair (Amst); 2008 May; 7(5):819-26. PubMed ID: 18343204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERCC1-XPF targeting to psoralen-DNA crosslinks depends on XPA and FANCD2.
    Sabatella M; Pines A; Slyskova J; Vermeulen W; Lans H
    Cell Mol Life Sci; 2020 May; 77(10):2005-2016. PubMed ID: 31392348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential binding of DNA repair proteins RPA and ERCC1 to XPA in vitro.
    Saijo M; Kuraoka I; Masutani C; Hanaoka F; Tanaka K
    Nucleic Acids Res; 1996 Dec; 24(23):4719-24. PubMed ID: 8972858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleotide excision repair by mutant xeroderma pigmentosum group A (XPA) proteins with deficiency in interaction with RPA.
    Saijo M; Takedachi A; Tanaka K
    J Biol Chem; 2011 Feb; 286(7):5476-83. PubMed ID: 21148310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple DNA binding domains mediate the function of the ERCC1-XPF protein in nucleotide excision repair.
    Su Y; Orelli B; Madireddy A; Niedernhofer LJ; Schärer OD
    J Biol Chem; 2012 Jun; 287(26):21846-55. PubMed ID: 22547097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new structural insight into XPA-DNA interactions.
    Hilton B; Shkriabai N; Musich PR; Kvaratskhelia M; Shell S; Zou Y
    Biosci Rep; 2014 Dec; 34(6):e00162. PubMed ID: 25385088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF beta promotes repair of bulky DNA damage through increased ERCC1/XPF and ERCC1/XPA interaction.
    Zheng H; Jarvis IWH; Bottai M; Dreij K; Stenius U
    Carcinogenesis; 2019 Jun; 40(4):580-591. PubMed ID: 30418489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle checkpoint abrogator UCN-01 inhibits DNA repair: association with attenuation of the interaction of XPA and ERCC1 nucleotide excision repair proteins.
    Jiang H; Yang LY
    Cancer Res; 1999 Sep; 59(18):4529-34. PubMed ID: 10493501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of DNA binding by human factor xeroderma pigmentosum complementation group A (XPA) provides insight into its interactions with nucleotide excision repair substrates.
    Sugitani N; Voehler MW; Roh MS; Topolska-Woś AM; Chazin WJ
    J Biol Chem; 2017 Oct; 292(41):16847-16857. PubMed ID: 28860187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the XPA-FEN1 Interaction Concern to Nucleotide Excision Repair or Beyond?
    Krasikova YS; Maltseva EA; Khodyreva SN; Evdokimov AN; Rechkunova NI; Lavrik OI
    Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair.
    Cummings M; Higginbottom K; McGurk CJ; Wong OG; Köberle B; Oliver RT; Masters JR
    Biochem Pharmacol; 2006 Jul; 72(2):166-75. PubMed ID: 16756962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Nucleotide Excision Repair Pathway Limits L1 Retrotransposition.
    Servant G; Streva VA; Derbes RS; Wijetunge MI; Neeland M; White TB; Belancio VP; Roy-Engel AM; Deininger PL
    Genetics; 2017 Jan; 205(1):139-153. PubMed ID: 28049704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.